BlackRock Fund Advisors has recently announced that it has increased stake in Microbot Medical Inc. (NASDAQ:MBOT) by 0.31%. After grabbing 0.15 million shares, the institutional investor is now in possession of 474.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 1.86% having worth around $0.23 million. Moreover, Morgan Stanley Smith Barney LLC increased its share by 251.0 to have a control over 35438.0 shares. And Citadel Securities LLC raised its holdings to 23243.0 shares by acquiring 23243.0 shares or 0.29% of the stake.
Microbot Medical Inc. (MBOT) concluded trading on 05/25/23 at a closing price of $2.12, with 4.1 million shares of worth about $8.69 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -47.52% during that period and on Thursday the price saw a gain of about 10.99%. Currently the company’s common shares owned by public are about 7.72M shares, out of which, 7.65M shares are available for trading.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 1 analysts are covering the MBOT stock and their offered price forecasts bring an average price target of $8.00. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $8.00 and could fall to a lowest price of $8.00. The stock’s current price level is 73.5% above of average price target set by the analysts, while a rise to estimated low would result in gain of 73.5% for the stock. However, touching the estimated high of $8.00 would mean a gain of 73.5% for the stock.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 0 times over the past 12 months. They bought 0 shares in 0 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
Vanguard Total Stock Market ETF, Vanguard Extended Market Index Fu, and AlphaCentric Robotics & Automatio are the top 3 mutual funds which are holding stakes in Microbot Medical Inc. Vanguard Total Stock Market ETF is currently holding 0.15 million shares of worth totaling $0.23 million. The company recently came buying 0.0 shares which brought its stake up to 1.89% of the company’s outstanding shares. AlphaCentric Robotics & Automatio, after buying 100000.0 shares, have now control over 1.23% of the stake in the company. It holds 0.0 shares of worth $0.15 million.
Microbot Medical Inc. (NASDAQ: MBOT) started trading at $1.96, above $0.05 from concluding price of the previous day. However, the stock later moved at a day high price of 2.3500, or with a gain of 10.99%. Stock saw a price change of 86.60% in past 5 days and over the past one month there was a price change of 39.02%. Year-to-date (YTD), MBOT shares are showing a performance of -29.57% which decreased to -54.99% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.00 but also hit the highest price of $6.33 during that period. The average intraday trading volume for Microbot Medical Inc. shares is 3.48 million. The stock is currently trading 51.45% above its 20-day simple moving average (SMA20), while that difference is up 20.63% for SMA50 and it goes to -39.71% lower than SMA200.
BlackRock Fund Advisors acquired 0.15 million shares of Microbot Medical Inc. having value of about $0.23 million. Data submitted at the U.S SEC by BlackRock Fund Advisors revealed that the firm now holds 474.0 shares in the company valued at close to $1004.88, or have control over 0.31% stake in the company. Microbot Medical Inc. (NASDAQ: MBOT) currently have 7.72M outstanding shares and institutions hold larger chunk of about 21.00% of that. Holding of mutual funds in the company is about 12.65% while other institutional holders and individual stake holders have control over 6.18% and 12.50% of the stake respectively.
The stock has a current market capitalization of $15.86M and its 3Y-monthly beta is at 3.17. It has posted earnings per share of -$1.82 in the same period. It has Quick Ratio of 4.30 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MBOT, volatility over the week remained 56.58% while standing at 25.11% over the month.
Analysts are in expectations that Microbot Medical Inc. (MBOT) stock would likely to be making an EPS of -$0.28 in the current quarter, while forecast for next quarter EPS is -$0.21 and it is $0 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.28 which is -$0.28 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.49 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -14.00%.
Analysts at 1 brokerage firms have issued recommendations for the Microbot Medical Inc. (MBOT)’s stock and average of those rates the stock at a “Moderate Buy” and assign it a score of 2.00. Out of those 1 Wall Street analysts, 1 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
